Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2007-11-26 until 2008-05-26
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP - Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Objective of study:
other: Absorption, distribution and excretion of 14C- Uvinul A Plus in rats at dose level of 100 mg/kg bw.
Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 417 (Toxicokinetics)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.36 (Toxicokinetics)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.7485 (Metabolism and Pharmacokinetics)
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: Japan/ MAFF: Guidelines on the Compiling of Test Results on Toxicity; Tests on In Vivo Fate in Animals, 2001
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
443-860-6
EC Name:
-
Cas Number:
302776-68-7
Molecular formula:
C24 H31 N O4
IUPAC Name:
hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate
Radiolabelling:
yes

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories, Sulzfeld Germany
- Age at study initiation: At least about 8 weeks at the date of administration
- Weight at study initiation: Mean weight for the female rats: 235.3 g. Mean weight for the male rats: 328.4 g.
- Housing: During the acclimatization and prior to the experiment in type III Macrolon cages.
During balance experiment in all-glass metabolism cages; type Metabowl (Jencons, Leighton Buzzard, UK).
During the experiment animals were housed individually with the cages being labelled with the project number, animal number, dose and time of first administration.
- Individual metabolism cages: yes
- Diet: Kliba lab diet (mouse/ rat "GLP") either pelleted (e.g . during acclimatization or in steel wire mesh cages) or as meal (e.g. in metabolism cages).
Origin: Provimi Kliba SA, 4303 Kaiseraugst, Switzerland ad libitum prior to and during the experiments.
- Water: Tap water ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20- 24°C
- Humidity (%): 30-70%
- Photoperiod (hrs dark / hrs light): Natural day/ light rhythm with additional artificial light as required during working hours.

IN-LIFE DATES: From: 2007-11-26 To: 2007-11-29

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Details on exposure:
The requested details in this field are not relavent for the present study (NA- not applicabe)
Duration and frequency of treatment / exposure:
A single oral administration (5mL/ kg bw; 0.5-2 MBq/ animal)
Doses / concentrations
Remarks:
Doses / Concentrations:
Nominal dose level of 100 mg/kg bw.
No. of animals per sex per dose / concentration:
24 animals
3 groups, 8 rats in each group (4 females, 4 males)
Group 1: Experiment group (bile duct cannulated at the testing laboratory) - one oral dose of 100 mg/kg bw
Group 2: Same as group 1- Repetition of the experiment
Group 3: Same treatment as in the other 2 groups (animals were delivered with bile duct catheters from the breeding lab) - Confirmation experiment
Control animals:
no
Positive control reference chemical:
No positive control
Details on study design:
- Dose selection rationale: 100 mg/kg bw was selected to be applied in this study as it was considered to exert no adverse effects based on a subchronic toxicity study in rats (OECD 408) and it represents a technically appropriate dose for the assessment of the bioavailability of radiolabelled test substance via the oral route.
Details on dosing and sampling:
PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: Urine, feces, bile, cage wash
- Time and frequency of sampling: Bile excretion was collected in three-hour time intervals up to 72 hours. Urine and feces were collected in 24 hours intervals up to 72 hours.
- Other: After the experiment, animals were sacrificed and the following tissues were checked for remaining radioactivity: stomach and stomach contents, gut and gut contents, carcass.

Statistics:
Mean values and SD were the only (required) calculated statistical parameters in the study.

Results and discussion

Preliminary studies:
No preliminary studies

Toxicokinetic / pharmacokinetic studies

Details on absorption:
In the present study the bioavailability after single oral administration of 14C-Hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate to rats at a dose level of 100 mg/kg bw was examined. The bioavailability was calculated as the sum of radioactivity found within 72 hours in bile (males: 11.28% , females: 19.76% of dose applied), urine (males: 13.79%, females: 22.62% of dose applied), cage wash (recoveries of 0.71% in males and 1.46% in females) and carcass (recoveries of 0.46% in males and 1.26% in females). Altogether the bioavailability was 26% and 45% of the administered dose in male and female rats respectively.
Details on distribution in tissues:
Not determined but radioactivity in the residual carcass was 0.46% in male animals and 1.26% of dose in female animals.
Details on excretion:
Total excretion of radioactivity within 72 hours:
Via bile: 11.28 % of the administered dose for male rats and 19.76 % of the administered dose for female rats.
Via urine: 13.79% of the administered dose for male rats and 22.62 % for female rats.
Via feces: 51.47% of the administered dose for male rats and 32.78% for female rats.
In cage wash: 0.71% (male rats) and 1.46 % (female rats) of the administered dose were recovered.

Metabolite characterisation studies

Metabolites identified:
not measured

Any other information on results incl. tables

The mean total recovery of radioactivity was found to be 79.84% and 88.05% of the applied dose after single oral administration of 100 mg/kg bw Hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate

to male and female rats, respectively.

Applicant's summary and conclusion